Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study
Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study
复制标题
DOI:
10.1016/s1474-4422(10)70270-2
复制
发表时间:
2010-12-01
期刊:
影响因子:
48
通讯作者:
Taylor, Terrie E.
中科院分区:
文献类型:
--
作者:
Birbeck, Gretchen L.;Molyneux, Malcolm E.;Taylor, Terrie E.
Background Cerebral malaria a disorder characterised by coma parasitaemia and no other evident cause of coma, is challenging to diagnose definitively in endemic regions that have high rates of asymptomatic parasitaemia and limited neurodiagnostic facilities A recently described malaria retinopathy improves diagnostic specificity We aimed to establish whether retinopathy positive cerebral malaria is a risk factor for epilepsy or other neurodisabilitiesMethods Between 2005 and 2007 we did a prospective cohort study of survivors of cerebral malaria with malaria retinopahy in Blantyre, Malawi Children with cerebral malaria were identified at the time of their index admission and age-matched to concurrently admitted children without coma or nervous system infection Initially matching of cases to controls was 1 1 but in 2006, enrolment criteria for cerebral malaria survivors were revised to limit inclusion to children with cerebral malaria and retinopathy on the basis of indirect ophthalmoscopic examination, matching was then changed to 1 2 and the revised inclusion criteria were applied retrospectively for children enrolled previously Clinical assessments at discharge and standardised nurse led follow up every 3 months thereafter were done to identify children with new seizure disorders or other neurodisabilities A Kaplan Meier survival analysis was done for incident epilepsyFindings 132 children with retinopathy positive cerebral malaria and 264 age matched, non comatose controls were followed up for a median of 495 days (IQR 195-819) 12 of 132 cerebral malaria survivors developed epilepsy versus none of 264 controls (odds ratio [OR] undefined p